2020 9月 09

Chinese Biotech Sector is Blowing Hot as M&A and IPO Deals Surge Amid Covid-19 Pandemic

Toto Ku, Datasite Senior Sales Director, provides comments on the outlook for the Chinese biotech sector, including the surge in M&A and IPO deals amid the COVID-19 pandemic. The South Morning China Post article highlights findings from a recent webinar discussion on Deal Drivers in the Healthcare and Life Sciences: Mainland China.

Datasite for Healthcare

Navigating the healthcare and life sciences industry has never been harder. Whether you’re looking at a licensing, listing or M&A, achieve your objective quickly and keep sensitive data secure with Datasite.

連絡先

Media Relations
Marta Carraro

Vice President, Communications

212.367.6162

marta.carraro@datasite.com

Investor Relations
Jennifer Percy

651.632.4009

jennifer.percy@datasite.com

あなたも好きかも:

DealTech: VDR Fight for Due Diligence Dominance Spreads Out Over Deal Cycle - Analysis

A fierce battle between virtual data room (VDR) providers to dominate due diligence - the mid-point of the M&A cycle - is spreading out across other points of the process of buying and selling companies, according to a series of interviews published by DealTech.

The Scott Becker Business Podcast: Featuring Thomas Fredell, Chief Product Officer at Datasite

The Scott Becker Business Podcast features a discussion with CPO Thomas Fredell on Datasite's business transformation, using innovation to solve customer pain points, and the importance of effective leadership.

Datasite Wins HKB Technology Excellence Award for its M&A Platform

Hong Kong Business Magazine features an article on Datasite's recognition as a 2020 fintech leader in mergers and acquisitions. Part of the publication's Technology Excellence Awards, Datasite was cited for its innovative platforms and applications, which help dealmakers simplify, streamline and accelerate M&A.